Improved survival time trends for glioblastoma using the SEER 17 population-based registries. - Wikidata - awgldk - TriplyDB

Improved survival time trends for glioblastoma using the SEER 17 population-based registries.

Improved survival time trends for glioblastoma using the SEER 17 population-based registries.

http://www.wikidata.org/entity/Q33828439

about

The epidemiology of glioma in adults: a "state of the science" review Epidemiologic and molecular prognostic review of glioblastoma The role of imaging in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.Impact of antiepileptic drugs on thrombocytopenia in glioblastoma patients treated with standard chemoradiotherapy.A nested case-control study of 277 prediagnostic serum cytokines and glioma.Assessment of clinical and nonclinical characteristics associated with health-related quality of life in patients with high-grade gliomas: a feasibility study.Treatment Patterns, Survival, and Healthcare Costs of Patients with Malignant Gliomas in a Large US Commercially Insured Population Odds of death after glioblastoma diagnosis in the United States by chemotherapeutic era.Age-specific cancer incidence rates increase through the oldest age groups.Analyzing temozolomide medication errors: potentially fatal Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?Glioblastoma treatment patterns, survival, and healthcare resource use in real-world clinical practice in the USA.Association between Prediagnostic Allergy-Related Serum Cytokines and Glioma.Treatment results of glioblastoma during the last 30 years in a single institute The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patients Effect of pretreatment clinical factors on overall survival in glioblastoma multiforme: a Surveillance Epidemiology and End Results (SEER) population analysis.Outcome and molecular characteristics of adolescent and young adult patients with newly diagnosed primary glioblastoma: a study of the Society of Austrian Neurooncology (SANO)Association Between Prediagnostic Serum 25-Hydroxyvitamin D Concentration and Glioma.The influence of regional health system characteristics on the surgical management and receipt of post operative radiation therapy for glioblastoma multiforme.Patterns of care and outcome for patients with glioblastoma diagnosed during 2008-2010 in Spain Time trends in glioblastoma multiforme survival: the role of temozolomide.Molecular mechanisms of temozolomide resistance in glioblastoma multiforme.Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities.Introduction, rationale, and methodology.The role of radiotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.The role of neuropathology in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.The role of cytotoxic chemotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.The role of targeted therapies in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.The role of cytoreductive surgery in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study.Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis.Temozolomide induces autophagy in primary and established glioblastoma cells in an EGFR independent manner.Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials.Risk of subsequent cancer among pediatric, adult and elderly patients following a primary diagnosis of glioblastoma multiforme: a population-based study of the SEER database.Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma.Oncological patterns of care and outcomes for 265 elderly patients with newly diagnosed glioblastoma in France.Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009.New prognostic factor telomerase reverse transcriptase promotor mutation presents without MR imaging biomarkers in primary glioblastoma.Survival trends of oligodendroglial tumor patients and associated clinical practice patterns: a SEER-based analysis.MiR-126 Regulates the ERK Pathway via Targeting KRAS to Inhibit the Glioma Cell Proliferation and Invasion.

P2860

Q28387839-541B8EFC-1EE1-44EC-A6E1-CC2EEF621EC6 Q28395302-80C331C0-1B6D-4808-AD4A-3AFBE1C6670F Q30797166-3613E1A8-6C1A-4ED1-A792-2BF5B1C1414A Q33400189-8CDD46B8-D4F9-4991-B06A-013B38CE715A Q33778545-A7A6398C-78C2-4F50-95B5-1547E35E5DD4 Q33797398-73C85DA6-385A-4EEB-B675-250A2A6C2BEA Q33805484-52CCD46D-B9DA-46BC-A3CA-F58AA8B9B9DC Q33913598-F9CE5036-88F7-4ED9-BAE2-0630FA6321A0 Q33994078-06CBE195-B723-48A9-8A7E-F9F945DA85F5 Q34443355-1D4561E3-2716-422F-A4E4-B31DF8914B2B Q35206264-7D518F06-FD9B-49D3-9509-12D0A94FDB9B Q35222941-B29BF91B-3DFF-4111-BFCA-116245A5CC51 Q35767586-182E3FBB-2924-448D-9E92-016DC655E80D Q35869502-15C4E15A-679F-4A22-9D2E-C931F93AE6D8 Q35886554-CB31DD1D-5EDA-4CA6-B91E-B741D29A03A3 Q36411906-A07BC58A-AA9D-414A-8426-7B49EA7942A0 Q36500411-33013BA0-7737-41A1-B105-3DB3CE57EE58 Q36786297-CB422252-D6D1-4A0C-9FC4-4DDC70D59FAF Q36811135-5F44539A-22C2-4F8E-8598-0A77797AF465 Q36866021-04E8A81B-9C04-45ED-B164-BD09868BE14D Q37312701-AD69B994-47F7-4856-8DBF-1736674563BA Q38010801-AC5B9036-B4EF-40F6-89F5-C9D3B5BB1444 Q38127413-4A0041D9-07C5-439E-A0D5-193240708CD6 Q38203242-FAED2CB0-33D1-4889-9DB2-00D64F627E53 Q38204289-8B650049-505B-4B51-8B36-DACA6C511FB5 Q38204718-DA4434DD-71BB-41F2-A9BC-3D13F876DFC7 Q38205133-50C4C5C1-D414-40A9-9855-18719DF59A4C Q38205134-159E6E09-9DFF-4963-9D35-7C4B65BC0E69 Q38206395-E39011ED-4455-46A6-8E44-4DB9DEA1D19D Q38401201-CD97CF45-F69D-4B72-8707-43FD5888B9A4 Q38401359-78AF188F-618E-4646-AACC-003BE1464A72 Q38697698-65F1B819-3A93-4109-B94D-F84DC843D8FA Q38720644-AF04C92C-AF3E-40E3-A42C-42CB0654185F Q38910832-F646D6F3-B28A-4345-9B78-C50546585F61 Q38978686-8A140793-3B2B-4B0F-BE7B-708B17E93F79 Q39250933-CD34AAF6-45D8-44A4-86E2-CE7659E4665C Q39843063-C91007C9-3B16-4C77-BC1B-95FEC1B4F26C Q40046161-ADC39FBB-D1BE-49D1-8673-029D28D692CE Q40229295-39001F65-F41D-45DA-9CF8-2791A208E2EA Q40999025-09D0C7BD-8C54-46BE-8D43-2DDA049CA5B1

P2860

Improved survival time trends for glioblastoma using the SEER 17 population-based registries.

http://www.wikidata.org/entity/Q33828439

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Improved survival time trends ...... 7 population-based registries.

@ast

Improved survival time trends ...... 7 population-based registries.

@en

type

label

Improved survival time trends ...... 7 population-based registries.

@ast

Improved survival time trends ...... 7 population-based registries.

@en

prefLabel

Improved survival time trends ...... 7 population-based registries.

@ast

Improved survival time trends ...... 7 population-based registries.

@en

P1433

Q33828439-B763C692-72ED-4E4F-8BF1-5BC82F7275AC

P1476

Q33828439-91F064CB-418D-4A4B-A343-D55D5B84C5D4

P2093

Q33828439-0A0D4BB4-2A31-4D4F-A513-2FA5D2F583EA

Q33828439-5816356D-AF04-4DA1-BEF1-024D4424EE61

Q33828439-885989B2-A22A-4343-9CE1-A52729533581

Q33828439-9A8C7F90-67F0-44F1-A794-09C2946053A9

Q33828439-9DD6A80B-C67C-451A-9A4F-B2C77CA95744

Q33828439-C5EA74A5-4D6C-4391-9A54-6BCA6D8BC182

Q33828439-CAB38648-9449-4331-BBBE-BC2E379A84C0

P2860

Q33828439-06E28F8F-B958-49E9-A1A7-9BE4E81DD127

Q33828439-0DDC3060-0734-4D5C-B9A6-744D7D672F91

Q33828439-0F4E71C1-CC0A-4C09-8F7A-0D6594708EBB

Q33828439-10FF41A7-10C9-4820-BF3B-2D9B4E422914

Q33828439-1801F5C5-1465-40C6-9C2B-8720CAB7DE33

Q33828439-427EDEEA-9101-4D9E-943F-834535BCCA0E

Q33828439-43B80FC9-56EB-41B6-85B6-4635D1B6FFAA

Q33828439-54478E77-A4E9-4369-85A9-E56F8CC1CD98

Q33828439-5E1EE7ED-8EAD-445B-B8CC-BBBAC731DC1D

Q33828439-607C3997-FBEF-48C8-9C6D-CC9387268A36

P2888

Q33828439-59CB6592-547F-488F-A819-342F099FFA78

P304

Q33828439-F7E06513-572B-425E-A772-ACA6E351EA11

P31

Q33828439-C14D50E7-CE18-4AEF-922A-B4C5EA31EDE2

P356

Q33828439-130D8BF3-DB34-4DDF-8B63-BB554DCD176E

P433

Q33828439-12B20888-3255-42A4-A2B8-08C2F994ABAC

P478

Q33828439-44488AFE-9CBD-4F9D-A2A3-58666EF5F1A3

P50

Q33828439-BD1E8136-5C0A-4474-B0DD-DB595CED210B

P577

Q33828439-FF204C48-0B7D-44DA-BB7A-CA0B4C96485F

P6179

Q33828439-B5091099-B2D6-45AA-A8CD-D3324F089D38

P698

Q33828439-C22CC273-F644-41BB-B172-2724FC3BFBE9

P932

Q33828439-3D6D0A86-2D63-484A-A4F2-C8EE5E8B5FF2

P356

S11060-011-0738-7

P1433

Journal of Neuro-Oncology

P1476

Improved survival time trends ...... 7 population-based registries.

@en

P2093

Andrew Howard

http://www.w3.org/2001/XMLSchema#string

Bridget J McCarthy

http://www.w3.org/2001/XMLSchema#string

John L Villano

http://www.w3.org/2001/XMLSchema#string

Ralph R Weichselbaum

http://www.w3.org/2001/XMLSchema#string

Steven J Chmura

http://www.w3.org/2001/XMLSchema#string

Therese A Dolecek

http://www.w3.org/2001/XMLSchema#string

Usama Mahmood

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Radiosurgical boost for primary high-grade gliomas.

Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06.

Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review.

NCI SEER public-use data: applications and limitations in oncology research.

Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.

Factors influencing survival in high-grade gliomas.

Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis

P2888

s11060-011-0738-7

P304

207-212

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-011-0738-7

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1036950322

http://www.w3.org/2001/XMLSchema#string

P698

21984115

http://www.w3.org/2001/XMLSchema#string

P932

4077033

http://www.w3.org/2001/XMLSchema#string